EditorialKommentar
Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2023.6197 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Haley B Naik. Beteiligte Einrichtung: Department of Dermatology, University of California, San Francisco. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Antimicrobial Stewardship. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Hidradenitis SuppurativaAntimicrobial StewardshipHumansErtapenemAnti-Bacterial AgentsSeverity of Illness Index
Substanzen
ErtapenemAnti-Bacterial Agents
Autor:innen und Institutionen
- Department of Dermatology, University of California, San Francisco.
- Associate Editor, JAMA Dermatology.
Zitieren
APA
Naik, H. B. (2024). Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2023.6197
Vancouver
Naik HB. Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2023.6197
BibTeX
@article{Naik2024,
author = {Naik, Haley B},
title = {Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2023.6197}
}
EUVIMED